Influx Healthtech Q2 Results
- BSE: -
- NSE: INFLUX
- ISIN: INE0MYZ01012
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
210.50
-3.85 (-1.80%)
-3.85 (-1.80%)Volume36.60 K
Updated: Fri 13 Mar, 2026 | 15:29:34
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹66.76 Cr.-
- Operating Profit₹12.98 Cr.-
- Profit After Tax₹10.01 Cr.-
- Operating Margin19.44%(NA%)
Note: Comparison is on YoY basis
Quarterly - Influx Healthtech Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | - | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 53.79 | - | N/A |
| Depreciation/ Amortization | 1.68 | - | N/A |
| Operating Income | 12.98 | - | N/A |
| Net Income | 10.01 | - | N/A |
| Other Operating Expenses Total | 9.47 | - | N/A |
| Net Income Before Taxes | 13.07 | - | N/A |
| Total Revenue | 66.76 | - | N/A |
| Selling/ General/ Admin Expenses Total | 5.09 | - | N/A |
| Diluted Normalized EPS | 4.33 | - | N/A |